✦ LIBER ✦

Paclitaxel as a component of initial chemotherapy of advanced ovarian cancer: is the controversy resolved

✍ Scribed by Maurie Markman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A meta-analysis of alkylating agents ver

✍ R. Osborne 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 167 KB

First-line chemotherapy with epidoxorubi

✍ A Romanini; L Tanganelli; F Carnino; A Fanucchi; R Lionetto; S Pastorino; S Cosi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 86 KB

A Phase I/II Study of Dose-Intense Pacli

✍ Elise C. Kohn; Gisele A. Sarosy; Patricia Davis; Michaele Christian; Charles E. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 154 KB

39 Topotecan versus treosulfan in recurr

✍ S. Loibl; W. Meier; A. du Bois; W. Kuhn; J. Pfisterer; R. Kimmig; S. Olbricht; B 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A phase II study of cetuximab/paclitaxel

✍ Jason Konner; Russell J. Schilder; Felicia A. DeRosa; Scott R. Gerst; William P. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Is paclitaxel a more cost-effective choi

✍ Kushnir, C.L.; Frick, K.; Zhao, Z.; Giuntoli, R.L. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 101 KB